Pediatricians reaffirm broader vaccine schedule, breaking with CDC’s reduced list

The American Academy of Pediatrics (AAP) issued its 2026 childhood and adolescent immunization schedule, continuing to recommend routine vaccination against 18 diseases—an approach that diverges sharply from the Centers for Disease Control and Prevention (CDC), which recently narrowed its schedule to fewer universally recommended vaccines. The split highlights a widening public health dispute over what should be standard for all children versus what should be limited to high-risk groups or decided through clinician-parent consultation.

According to coverage of the AAP update, the academy’s recommendations retain vaccines that the CDC’s revised guidance no longer lists as routine for every child, including shots tied to influenza, COVID-19, rotavirus, hepatitis A and B, RSV, meningococcal disease and others. Pediatric infectious-disease specialists have argued that broad coverage is designed to prevent outbreaks and protect children before they are exposed, not after risk becomes obvious.

The CDC’s change has drawn criticism from medical groups and public health advocates who say the revision risks confusion, lower uptake, and widening vulnerability, particularly during a season when respiratory viruses can surge and misinformation spreads quickly online. Supporters of the CDC’s approach argue it better reflects international norms and emphasizes informed consent, but opponents say the U.S. health system and disease burden make a narrower schedule difficult to justify.

For parents, the practical reality is that vaccine decisions are still made in clinics, and state requirements for school or childcare can differ from federal guidance. Pediatricians recommend discussing the updated AAP schedule with a child’s doctor and focusing on timely protection, especially for infants and toddlers who are most vulnerable to severe complications. The policy fight is likely to continue in courts, legislatures, and medical societies, but the AAP is signaling it will keep promoting the broader schedule it says is backed by long-running evidence.